Frank Striggow
Directeur des opérations chez Life Science Inkubator GmbH
Profil
Frank Striggow is the founder of KeyNeurotek Pharmaceuticals AG, which was founded in 2000.
He held the title of Chief Executive Officer in 2010.
Currently, he holds positions at American Heart Association, Inc. as a Member and at Life Science Inkubator GmbH as Chief Operating Officer.
In the past, he held positions as Principal at the University of Connecticut Health Center and The Marine Biological Laboratory.
He also held the position of Principal at Otto-von-Guericke-Universität Magdeburg from 1996 to 2001.
Postes actifs de Frank Striggow
| Sociétés | Poste | Début |
|---|---|---|
American Heart Association, Inc.
 American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | Corporate Officer/Principal | - |
Life Science Inkubator GmbH
 Life Science Inkubator GmbH Investment ManagersFinance Life Science Inkubator GmbH (LSI) is the venture capital subsidiary of Max-Planck-Innovation GmbH, itself a subsidiary of Max Planck Gesellschaft zur Förderung der Wissenschaften eV. The firm was founded in 2007 and is headquartered in Bonn, Germany. | Directeur des opérations | - |
Anciens postes connus de Frank Striggow
| Sociétés | Poste | Fin |
|---|---|---|
KeyNeurotek Pharmaceuticals AG
 KeyNeurotek Pharmaceuticals AG Pharmaceuticals: OtherHealth Technology KeyNeurotek Pharmaceuticals AG is a biopharmaceutical company focused on the development of innovative small molecule drugs for the treatment of neuronal and autoimmune diseases. KeyNeurotek’s drug portfolio covers the entire drug development chain from research stage to advanced clinical development. At present, two compounds are in clinical development, KN38-7271 and KN203, both addressing significant markets such as traumatic brain injury, TBI, stroke, and urinary incontinence/overactive bladder. The company’s product development is based on its proprietary technology platform, which has been specifically tailored to diseases of the central nervous system, TELOMICS. KeyNeurotek was founded by Dr Frank Striggow, Frank Baumgart, Prof Dr Klaus G. Reymann and Prof Dr Henning Scheich in May 2000. The company is located in Magdeburg, Germany. | Fondateur | 21/07/2010 |
| Otto-von-Guericke-Universität Magdeburg | Corporate Officer/Principal | 01/01/2001 |
The Marine Biological Laboratory
 The Marine Biological Laboratory Miscellaneous Commercial ServicesCommercial Services The Marine Biological Laboratory provides research and educational services. It offers a range of courses, workshops, conferences, and internships, discovery-based education programs and courses. The firm s a private marine laboratory, supporting scientists and staff working in such fields as cell and developmental biology, ecology, microbiology, molecular evolution, global infectious disease, neurobiology, and sensory physiology. The company was founded in 1888 and is headquartered in Woods Hole, MA. | Corporate Officer/Principal | - |
University of Connecticut Health Center
 University of Connecticut Health Center Other Consumer ServicesConsumer Services University of Connecticut Health Center provides healthcare services. It is an organization, which composed of the school of medicine, John Dempsey hospital, the UConn medical group & health partners, and university dentists. It offers services for cardiovascular, cancer, behavioral, ambulatory, and neonatal intensive-care. The company was founded in 1961 and is headquartered in Farmington, CT. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
KeyNeurotek Pharmaceuticals AG
KeyNeurotek Pharmaceuticals AG Pharmaceuticals: OtherHealth Technology KeyNeurotek Pharmaceuticals AG is a biopharmaceutical company focused on the development of innovative small molecule drugs for the treatment of neuronal and autoimmune diseases. KeyNeurotek’s drug portfolio covers the entire drug development chain from research stage to advanced clinical development. At present, two compounds are in clinical development, KN38-7271 and KN203, both addressing significant markets such as traumatic brain injury, TBI, stroke, and urinary incontinence/overactive bladder. The company’s product development is based on its proprietary technology platform, which has been specifically tailored to diseases of the central nervous system, TELOMICS. KeyNeurotek was founded by Dr Frank Striggow, Frank Baumgart, Prof Dr Klaus G. Reymann and Prof Dr Henning Scheich in May 2000. The company is located in Magdeburg, Germany. | Health Technology |
American Heart Association, Inc.
American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | Commercial Services |
The Marine Biological Laboratory
The Marine Biological Laboratory Miscellaneous Commercial ServicesCommercial Services The Marine Biological Laboratory provides research and educational services. It offers a range of courses, workshops, conferences, and internships, discovery-based education programs and courses. The firm s a private marine laboratory, supporting scientists and staff working in such fields as cell and developmental biology, ecology, microbiology, molecular evolution, global infectious disease, neurobiology, and sensory physiology. The company was founded in 1888 and is headquartered in Woods Hole, MA. | Commercial Services |
Life Science Inkubator GmbH
Life Science Inkubator GmbH Investment ManagersFinance Life Science Inkubator GmbH (LSI) is the venture capital subsidiary of Max-Planck-Innovation GmbH, itself a subsidiary of Max Planck Gesellschaft zur Förderung der Wissenschaften eV. The firm was founded in 2007 and is headquartered in Bonn, Germany. | Finance |